Executive Summary
Transaction Value
£8+
In a significant market movement during March 2026, Callosum was the subject of a high-profile vc funding. The transaction achieved a gross valuation exceeding £8.
This transaction was successfully brokered and advised by an undisclosed entity. The deal reflects ongoing market confidence and strategic positioning within its respective sector.
Lead Investor / Acquirer
Undisclosed Group
Original Brief
View the original external press release, news article, or listing describing this transaction in full detail.
Read Original SourceHave intel on this deal?
If you were involved in this transaction and would like to claim it, update the details, or redact specific pricing data, you can submit a query.
Contact Support